We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Top Buys

Rank Stock Value
1
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$6.56M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.36M
3
ILMN icon
Illumina
ILMN
+$3.21M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3M
5
RBA icon
RB Global
RBA
+$2.93M

Top Sells

Rank Stock Value
1
PFFD icon
Global X US Preferred ETF
PFFD
+$5.94M
2
VST icon
Vistra
VST
+$5.92M
3
GDDY icon
GoDaddy
GDDY
+$5M
4
SMCI icon
Super Micro Computer
SMCI
+$4.37M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$4M

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSBC icon
2201
Great Southern Bancorp
GSBC
$877M
$44.3K ﹤0.01%
796
– –
SMBC icon
2202
Southern Missouri Bancorp
SMBC
$850M
$44.2K ﹤0.01%
983
– –
CEVA icon
2203
CEVA Inc
CEVA
$855M
$44.2K ﹤0.01%
2,293
– –
MLAB icon
2204
Mesa Laboratories
MLAB
$631M
$44.2K ﹤0.01%
509
– –
HONE
2205
DELISTED
HarborOne Bancorp
HONE
$44.1K ﹤0.01%
3,960
– –
CDMO
2206
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$44K ﹤0.01%
6,166
– –
APLT
2207
DELISTED
Applied Therapeutics
APLT
$44K ﹤0.01%
+9,419
New +$44.6K
KALV
2208
DELISTED
KalVista Pharmaceuticals
KALV
$44K ﹤0.01%
3,731
+1,263
+51% +$14.7K
ROOT icon
2209
Root
ROOT
$748M
$43.7K ﹤0.01%
+846
New +$49K
GDOT icon
2210
Green Dot
GDOT
$766M
$43.6K ﹤0.01%
4,617
– –
IVR icon
2211
Invesco Mortgage Capital
IVR
$805M
$43.6K ﹤0.01%
4,656
– –
ACCO icon
2212
Acco Brands
ACCO
$399M
$43.5K ﹤0.01%
9,262
– –
MCB icon
2213
Metropolitan Bank Holding Corp
MCB
$1.17B
$43.5K ﹤0.01%
1,034
– –
DMRC icon
2214
Digimarc Corp
DMRC
$167M
$43.5K ﹤0.01%
1,402
– –
SMRT icon
2215
SmartRent
SMRT
$276M
$43.4K ﹤0.01%
18,178
– –
SGHC icon
2216
SGHC Ltd
SGHC
$6.51B
$43.2K ﹤0.01%
13,369
– –
SEAT icon
2217
Vivid Seats
SEAT
$81.6M
$42.8K ﹤0.01%
372
– –
TTI icon
2218
TETRA Technologies
TTI
$1.29B
$42.8K ﹤0.01%
12,362
– –
THFF icon
2219
First Financial Corp
THFF
$970M
$42.7K ﹤0.01%
1,159
– –
ORIC icon
2220
Oric Pharmaceuticals
ORIC
$1.42B
$42.6K ﹤0.01%
6,032
+2,809
+87% +$25.1K
EYPT icon
2221
EyePoint Inc
EYPT
$1.16B
$42.6K ﹤0.01%
4,898
+1,179
+32% +$16.5K
GTN icon
2222
Gray Television
GTN
$520M
$42.5K ﹤0.01%
8,170
– –
HTZ icon
2223
Hertz
HTZ
$838M
$42.4K ﹤0.01%
12,023
-17,994
-60% -$91.5K
LQDT icon
2224
Liquidity Services
LQDT
$1.35B
$42.4K ﹤0.01%
2,122
– –
OLMA icon
2225
Olema Pharmaceuticals
OLMA
$913M
$42.3K ﹤0.01%
3,912
+1,695
+76% +$18.4K
87 88
89
90 91

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.